Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients.
BTG Commences Phase IIa Study of Multiple Sclerosis
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Effects of an aqueous extract of North American ginseng on MOG((35-55))-induced EAE in mice.
Idebenone for primary progressive multiple sclerosis
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
Long-Term Safety and Efficacy Study of BIIB017 (PEGylated Interferon Beta-1a) (ATTAIN)
Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?
[The Sjögren's syndrome and multiple sclerosis: similarity and differences.]
First patient treated in Mapi Pharma's Phase IIa clinical trial of GA Depot for relapsing remitting multiple sclerosis (RRMS)
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
First proof for rituximab in IgG4-related disease
Neuroprotective effect of masitinib in rats with postischemic stroke.
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Extoxnet (extension toxicology network), 4-aminopyridine
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Rituximab Use in Pediatric Central Demyelinating Disease.
[Nicolau syndrome after administration of glatiramer acetate].
Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multipl
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.

Pages